Schering

However, you might ask your vet where to get this simple injection for your cat or call Schering Plough Corporation at 908-298-4000.

250 Things You Can Do to Make Your Cat Adore You INGRID NEWKIRK 1998

However, you might ask your vet where to get this simple injection for your cat or call Schering Plough Corporation at 908-298-4000.

250 Things You Can Do to Make Your Cat Adore You INGRID NEWKIRK 1998

J & J believes Merck's takeover of Schering triggered a change-of-control clause in J & J's longstanding Remicade partnership with Schering, which J & J says should result in full rights reverting to it.

Merck's Profit Takes Hit From Vioxx Charge Peter Loftus 2010

Specifically, the deal was a "reverse merger" in which Schering was the surviving corporation, even though it retained Merck's name, leadership and headquarters.

Rivals Resolve Dispute Over Drug Peter Loftus 2011

Aside from trying to put the Vioxx case behind it, Merck is busy integrating its November 2009 acquisition of Schering-Plough for $49.6 billion.

Merck's Profit Takes Hit From Vioxx Charge Peter Loftus 2010

Third-quarter sales jumped 84% to $11.1 billion largely on the Schering acquisition, which closed in November 2009, but fell short of the $11.2 billion Thomson estimate.

Merck's Profit Takes Hit From Vioxx Charge Peter Loftus 2010

Merck spokesman Ron Rogers said the work to prepare for the payment disclosures began before the Schering deal closed, and it's still integrating the Schering data.

Merck Paid $20.4 Million in Speaking Fees to U.S. Doctors Peter Loftus 2011

J&J claimed the deal nullified its longstanding Remicade marketing partnership with Schering-Plough, and that Schering's rights to distribute the drugs should revert to J&J under a change-of-control provision.

Rivals Resolve Dispute Over Drug Peter Loftus 2011

CEO Mr. Frazier hinted Friday that Merck wasn't likely to divest itself of some of the nonpharmaceutical businesses Merck acquired in the Schering deal.

Merck's Profit Soars on Lower Charges Peter Loftus 2011

William W. Busse, M.D., from the University of Wisconsin School of Medicine and Public Health, chaired the expert panel which developed the government's 2007 National Asthma Education and Prevention Program Guidelines -- even though he is financially linked to GlaxoSmithKline, Merck, Novartis, Pfizer Genentech/Novartis, Schering and five other Pharma companies.

Martha Rosenberg: Are You Taking These Asthma Drugs? Martha Rosenberg 2011